209 related articles for article (PubMed ID: 23843989)
1. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.
Wang HH; Hung CC; Hwang DY; Kuo MC; Chiu YW; Chang JM; Tsai JC; Hwang SJ; Seifter JL; Chen HC
PLoS One; 2013; 8(7):e67140. PubMed ID: 23843989
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA
Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674
[TBL] [Abstract][Full Text] [Related]
3. Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.
Kieneker LM; Eisenga MF; Joosten MM; de Boer RA; Gansevoort RT; Kootstra-Ros JE; Navis G; Bakker SJ
PLoS One; 2017; 12(3):e0174686. PubMed ID: 28346526
[TBL] [Abstract][Full Text] [Related]
4. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
[TBL] [Abstract][Full Text] [Related]
5. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
[TBL] [Abstract][Full Text] [Related]
6. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
[TBL] [Abstract][Full Text] [Related]
7. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
[TBL] [Abstract][Full Text] [Related]
8. Association of Low Serum Potassium Levels and Risk for All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Zhang Y; Chen P; Chen J; Wang L; Wei Y; Xu D
Ther Apher Dial; 2019 Feb; 23(1):22-31. PubMed ID: 30239143
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
Maddirala S; Khan A; Vincent A; Lau K
Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
[TBL] [Abstract][Full Text] [Related]
10. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Bicarbonate and CKD Progression in Children.
Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
[TBL] [Abstract][Full Text] [Related]
12. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
[TBL] [Abstract][Full Text] [Related]
14. Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care.
Borrelli S; De Nicola L; Minutolo R; Conte G; Chiodini P; Cupisti A; Santoro D; Calabrese V; Giannese D; Garofalo C; Provenzano M; Bellizzi V; Apicella L; Piccoli GB; Torreggiani M; Di Iorio BR
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33804015
[TBL] [Abstract][Full Text] [Related]
15. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
16. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
Luo J; Brunelli SM; Jensen DE; Yang A
Clin J Am Soc Nephrol; 2016 Jan; 11(1):90-100. PubMed ID: 26500246
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Potassium Supplementation in Hypokalemic Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial.
Pichitporn W; Kanjanabuch T; Phannajit J; Puapatanakul P; Chuengsaman P; Parapiboon W; Treamtrakanpon W; Boonyakrai C; Matayart S; Katavetin P; Perl J; Praditpornilpa K; Eiam-Ong S; Tungsanga K; Johnson DW
Am J Kidney Dis; 2022 Nov; 80(5):580-588.e1. PubMed ID: 35597332
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
19. Association between Hypokalemia and Albuminuria in a Japanese General Population.
Toda A; Hara S; Honda R; Arase Y
Nephron; 2023; 147(7):417-423. PubMed ID: 36724744
[TBL] [Abstract][Full Text] [Related]
20. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
